126 related articles for article (PubMed ID: 8221517)
1. Role of Borrelia burgdorferi in lymphocytomas and sclerotic skin lesions.
Hovmark A
Clin Dermatol; 1993; 11(3):363-7. PubMed ID: 8221517
[No Abstract] [Full Text] [Related]
2. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.
Schempp C; Bocklage H; Lange R; Kölmel HW; Orfanos CE; Gollnick H
J Invest Dermatol; 1993 May; 100(5):717-20. PubMed ID: 8491994
[TBL] [Abstract][Full Text] [Related]
3. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma.
Wienecke R; Schlüpen EM; Zöchling N; Neubert U; Meurer M; Volkenandt M
J Invest Dermatol; 1995 Jan; 104(1):23-6. PubMed ID: 7798636
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of Borrelia burgdorferi in the skin.
Aberer E; Kersten A; Klade H; Poitschek C; Jurecka W
Am J Dermatopathol; 1996 Dec; 18(6):571-9. PubMed ID: 8989928
[TBL] [Abstract][Full Text] [Related]
5. A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea.
Aberer E; Klade H; Hobisch G
Am J Dermatopathol; 1991 Aug; 13(4):334-41. PubMed ID: 1928618
[TBL] [Abstract][Full Text] [Related]
6. The expanding spectrum of cutaneous borreliosis.
Eisendle K; Zelger B
G Ital Dermatol Venereol; 2009 Apr; 144(2):157-71. PubMed ID: 19357623
[TBL] [Abstract][Full Text] [Related]
7. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
Ross SA; Sánchez JL; Taboas JO
Am J Dermatopathol; 1990 Aug; 12(4):357-62. PubMed ID: 2393064
[TBL] [Abstract][Full Text] [Related]
8. [Using the polymerase chain reaction to Borrelia burgdorferi infection in localized scleroderma injure (morphea), in Venezuelan patients].
Espinoza-León F; Arocha F; Hassanhi M; Arévalo J
Invest Clin; 2010 Sep; 51(3):381-90. PubMed ID: 21305774
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans.
Wienecke R; Zöchling N; Neubert U; Schlüpen EM; Meurer M; Volkenandt M
J Invest Dermatol; 1994 Jul; 103(1):19-22. PubMed ID: 8027576
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
11. Identification of three species of Borrelia burgdorferi sensu lato (B. burgdorferi sensu stricto, B. garinii, and B. afzelii) among isolates from acrodermatitis chronica atrophicans lesions.
Picken RN; Strle F; Picken MM; Ruzic-Sabljic E; Maraspin V; Lotric-Furlan S; Cimperman J
J Invest Dermatol; 1998 Mar; 110(3):211-4. PubMed ID: 9506437
[TBL] [Abstract][Full Text] [Related]
12. A case of generalized morphea with a high titer of anti-Borrelia burgdorferi antibodies.
Nakashima T; Maeda M; Hayashi T; Kitamura K
J Dermatol; 1999 Dec; 26(12):821-4. PubMed ID: 10659505
[TBL] [Abstract][Full Text] [Related]
13. Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea).
Fan W; Leonardi CL; Penneys NS
J Am Acad Dermatol; 1995 Oct; 33(4):682-4. PubMed ID: 7673508
[No Abstract] [Full Text] [Related]
14. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea).
Meis JF; Koopman R; van Bergen B; Pool G; Melchers W
Arch Dermatol; 1993 Mar; 129(3):386-7. PubMed ID: 8447688
[No Abstract] [Full Text] [Related]
15. Borrelia burgdorferi and localized scleroderma.
Trevisan G; Rees DH; Stinco G
Clin Dermatol; 1994; 12(3):475-9. PubMed ID: 7954205
[No Abstract] [Full Text] [Related]
16. Acrodermatitis chronica atrophicans.
Asbrink E
Clin Dermatol; 1993; 11(3):369-75. PubMed ID: 8221518
[No Abstract] [Full Text] [Related]
17. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
Dillon WI; Saed GM; Fivenson DP
J Am Acad Dermatol; 1995 Oct; 33(4):617-20. PubMed ID: 7673495
[TBL] [Abstract][Full Text] [Related]
18. Isolation of Borrelia burgdorferi sensu lato from a fibrous nodule in a patient with acrodermatitis chronica atrophicans.
Maraspin V; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):533-4. PubMed ID: 12422596
[TBL] [Abstract][Full Text] [Related]
19. The absence of antibodies against Borrelia burgdorferi in the sera of Japanese patients with localized scleroderma.
Akimoto S; Ishikawa O; Miyachi Y
J Rheumatol; 1996 Mar; 23(3):573-4. PubMed ID: 8833012
[No Abstract] [Full Text] [Related]
20. Acrodermatitis chronic atrophicans: a chronic T-cell-mediated immune reaction against Borrelia burgdorferi? Clinical, histologic, and immunohistochemical study of five cases.
Buechner SA; Rufli T; Erb P
J Am Acad Dermatol; 1993 Mar; 28(3):399-405. PubMed ID: 8095272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
